Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Covidien (COV +1.2%) continues the rise it began on Tuesday last week ahead of its FQ3 EPS beat...

  • Monday, July 30, 2012, 11:14 AM ET
    Covidien (COV +1.2%) continues the rise it began on Tuesday last week ahead of its FQ3 EPS beat on Thursday and hits a new 52-week high of $56.21. SA author Stephen Simpson calls Covidien "a leading growth story at a reasonable price." The company today said it has received 510(K) clearance for its Nellcor Bedside SpO2 Patient Monitoring System.
Track new comments on this story

This news story has 1 comment:

  •  
    And this has to with Kellogg (K) how?
    30 Jul 2012, 12:45 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »